Billionaire Bill Gates Foundation Bought Just 2 Stocks in Q3, and Its Bullish for This Sector
BIVRX Fund | USD 17.16 0.25 1.48% |
Slightly above 52% of Balter Invenomic's investors are presently thinking to get in. The analysis of overall sentiment of trading Balter Invenomic Fund mutual fund suggests that some investors are interested at this time. Balter Invenomic's investing sentiment can be driven by a variety of factors including economic data, Balter Invenomic's earnings reports, geopolitical events, and overall market trends.
Balter |
Bill Gates is one of the most famous businessmen in the world. The Microsoft founder is still one of the richest people in the world, and the foundations portfolio reflects that as it has more than 45 billion in assets under management.
Read at finance.yahoo.com
Balter Invenomic Fundamental Analysis
We analyze Balter Invenomic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Balter Invenomic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Balter Invenomic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Balter Invenomic is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Balter Invenomic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Balter Invenomic mutual fund to make a market-neutral strategy. Peer analysis of Balter Invenomic could also be used in its relative valuation, which is a method of valuing Balter Invenomic by comparing valuation metrics with similar companies.
Peers
Balter Invenomic Related Equities
NEITX | Nebraska Municipal | 0.32 | ||||
OKMUX | Oklahoma Municipal | 0.28 | ||||
BXDYX | Barings Active | 0.22 | ||||
PATFX | T Rowe | 0.18 | ||||
MGGNX | Mirova Global | 0.11 | ||||
MDMTX | Blrc Sgy | 0.09 | ||||
TTRBX | Ambrus Core | 0.10 | ||||
BSGAX | Sterling Capital | 0.12 |
Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world |